Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Sales (2020 - 2026)

Cytek Biosciences filings provide 6 years of Return on Sales readings, the most recent being 0.01% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 1.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.01% in Q4 2025 for Cytek Biosciences, down from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2024 to a low of 0.01% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.0% (2022), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Sales: changed 0bps in 2021 and later decreased -1bps in 2025.
  • Cytek Biosciences' Return on Sales stood at 0.0% in 2021, then soared by 474bps to 0.0% in 2022, then increased by 23bps to 0.0% in 2023, then soared by 77bps to 0.0% in 2024, then tumbled by -525bps to 0.01% in 2025.
  • The last three reported values for Return on Sales were 0.01% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.